Visual aids may reduce unnecessary procedures for chest pain patients

Researchers from the Mayo Clinic in Rochester, Minn., discovered that individuals who were admitted to the emergency room for chest pain were less likely to opt for unnecessary procedures after doctors shared educational visual aids with them. The results suggested that patient education brochures and other demonstrative tools may be useful for reducing costs associated with medically unnecessary tests and treatments.

In order to investigate how such tools may affect patients' decision making, the team of scientists developed a visual patient-education tool for individuals admitted to the emergency room for chest pain. This aid provided information about various care options and the 45-day risk of a heart attack. Within a study cohort of 204 individuals from one emergency department, the researchers showed the visual aid to one-half of subjects.

Results showed that patients who saw the decision-making tool opted to undergo stress testing 58 percent of the time. By comparison, those who never saw the aid chose testing 77 percent of the time.

Furthermore, subjects who saw this information became more knowledgeable about their heart attack risk compared to the other patients. Patients in the former group were also four times more involved with their medical decision making.

Those who saw the aid described it as clear and helpful. About 75 percent of them said they would recommend it to other individuals.

There were no adverse events in the 30 days following discharge for any study participants.

These findings may have implications for the estimated 8 million yearly patient visits to hospitals that are attributed to chest pain. Reducing the incidence of false positive stress tests and radiation exposure may reduce medical costs associated with chest pain, which currently total $8 billion a year.

"Informing patients of their risk and engaging them in the decision-making process may enable physicians and patients to work together to choose an approach to evaluation that is more in line with what patients want, without negatively affecting the results of their health care," said lead researcher Erik Hess, M.D., M.Sc.

These results need to be verified in a study of several other hospital emergency departments, the authors noted.



<< Back to News

Related Articles

New survey finds more than 98 percent of physicians experienced cancer drug shortages

Across the country, widespread shortages in cancer-treating drugs have led to higher costs, severe side effects and the progression of the disease for many patients, according to a recent survey conducted by the Community Oncology Alliance (COA), a nonprofit organization dedicated to mobilizing community cancer care. These trends may have long-term implications on the pharmaceutical marketing potential for brand name and generic treatment drugs.

Online portal for Hepatitis C makes information easy to access for community

Boehringer Ingelheim Pharmaceuticals, one of the world's leading pharmaceutical companies, has launched an online portal designed to help those affected by the hepatitis C virus (HCV) gain greater understanding about the condition through education and information. The website is an example of healthcare marketing that incorporates video and other online tools to disseminate relevant information to those in the HCV community.

Government incentives, cost concerns may drive sales of infusion pumps

The federal government's encouragement of electronic medical records (EMRs) and reduced hospital readmissions, as well as concerns about cost cutting, may boost the sales of infusion pumps in the U.S., according to a report from Millennium Research Group. The findings of this study may inform the marketing for medical devices, such as infusion pumps that can be integrated into EMR systems.